06/10/2025
8:29 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2025
9:38 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2025
9:40 AM | Unicycive Therapeutics (Filer)
| Form DEFA14A | |
05/21/2025
7:04 PM | Unicycive Therapeutics (Filer)
| Form DEFA14A | |
05/21/2025
8:17 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2025
8:19 AM | Unicycive Therapeutics (Filer)
| Form DEFA14A | |
05/15/2025
3:39 PM | Nantahala Capital Management, LLC (Filed by)
Unicycive Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/15/2025
7:30 AM | Unicycive Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
05/14/2025
7:01 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2025
6:05 AM | Unicycive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2025
3:21 PM | Unicycive Therapeutics (Filer)
| Form DEFA14A | |
Get the Latest News and Ratings for UNCY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Unicycive Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/31/2025
8:15 AM | Unicycive Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/19/2025
10:55 AM | Aggarwal Gaurav (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:43 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Unicycive Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
3:39 PM | GREAT POINT PARTNERS LLC (Filed by)
Unicycive Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/06/2025
2:08 PM | Unicycive Therapeutics (Subject)
Walleye Capital LLC (Filed by)
| Form SCHEDULE 13G/A | |
01/07/2025
3:15 PM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
3:31 PM | Nantahala Capital Partners Limited Partnership (Filed by)
Unicycive Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
12/20/2024
3:32 PM | Nantahala Capital Management, LLC (Filed by)
Unicycive Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
11/20/2024
11:15 PM | Unicycive Therapeutics (Filer)
| Form EFFECT | |
11/14/2024
11:15 PM | Unicycive Therapeutics (Filer)
| Form EFFECT | |
11/14/2024
6:13 PM | Logos Global Management LP (Filed by)
Unicycive Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
6:01 PM | Unicycive Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:46 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Unicycive Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
3:53 PM | Nantahala Capital Management, LLC (Filed by)
Unicycive Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
11/14/2024
3:53 PM | Nantahala Capital Partners Limited Partnership (Filed by)
Unicycive Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
11/13/2024
4:29 PM | Unicycive Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/13/2024
3:52 PM | Unicycive Therapeutics (Subject)
Walleye Capital LLC (Filed by)
| Form SC 13G | |
11/13/2024
3:05 PM | Unicycive Therapeutics (Filer)
| Form POS AM | |
11/13/2024
7:04 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
6:05 AM | Unicycive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2024
4:15 PM | Aggarwal Gaurav (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
7:54 PM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
7:11 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
6:05 AM | Unicycive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/18/2024
3:10 PM | GREAT POINT PARTNERS LLC (Filed by)
Unicycive Therapeutics (Subject)
| Form SC 13G | |
07/16/2024
11:15 PM | Unicycive Therapeutics (Filer)
| Form EFFECT | |
07/16/2024
9:31 AM | Unicycive Therapeutics (Filer)
| Form 424B3 | |
07/15/2024
3:15 PM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
3:15 PM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
4:20 PM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Want to front-run Warren Buffett? (Ad) A Historic Gold Announcement Is About to Rock Wall Street?
For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains. Click here to get Garrett’s Top Four picks now. |
06/25/2024
8:15 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy UNCY Stock Free UNCY Stock Alerts